DADLE improves hepatic ischemia/reperfusion injury in mice via activation of the Nrf2/HO‑1 pathway

  • Authors:
    • Yi Zhou
    • Jing Zhang
    • Biao Lei
    • Wenjin Liang
    • Jianhua Gong
    • Chuanxiang Zhao
    • Jidong Yu
    • Xuan Li
    • Bo Tang
    • Shengguang Yuan
  • View Affiliations

  • Published online on: August 29, 2017     https://doi.org/10.3892/mmr.2017.7393
  • Pages: 6214-6221
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hepatic ischemia/reperfusion (I/R) injury is a common pathophysiological process that occurs following liver surgery, which is associated with oxidative stress, and can cause acute liver injury and lead to liver failure. Recently, the development of drugs for the prevention of hepatic I/R injury has garnered interest in the field of liver protection research. Previous studies have demonstrated that [D‑Ala2, D‑Leu5]‑Enkephalin (DADLE) exerts protective effects against hepatic I/R injury. To further clarify the specific mechanism underlying the effects of DADLE on hepatic I/R injury, the present study aimed to observe the effects of various doses of DADLE on hepatic I/R injury in mice. The results indicated that DADLE, at a concentration of 5 mg/kg, significantly reduced the levels of alanine aminotransferase and aspartate aminotransferase in the serum, and the levels of malondialdehyde in the liver homogenate. Conversely, the levels of glutathione, catalase and superoxide dismutase in the liver homogenate were increased. In addition, DADLE was able to promote nuclear factor, erythroid 2 like 2 (Nrf2) nuclear translocation and upregulate the expression of heme oxygenase (HO)‑1, which is a factor downstream of Nrf2, thus improving hepatic I/R injury in mice. In conclusion, the present study demonstrated that DADLE was able to significantly improve hepatic I/R injury in mice, and the specific mechanism may be associated with the Nrf2/HO‑1 signaling pathway.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 16 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou Y, Zhang J, Lei B, Liang W, Gong J, Zhao C, Yu J, Li X, Tang B, Yuan S, Yuan S, et al: DADLE improves hepatic ischemia/reperfusion injury in mice via activation of the Nrf2/HO‑1 pathway. Mol Med Rep 16: 6214-6221, 2017.
APA
Zhou, Y., Zhang, J., Lei, B., Liang, W., Gong, J., Zhao, C. ... Yuan, S. (2017). DADLE improves hepatic ischemia/reperfusion injury in mice via activation of the Nrf2/HO‑1 pathway. Molecular Medicine Reports, 16, 6214-6221. https://doi.org/10.3892/mmr.2017.7393
MLA
Zhou, Y., Zhang, J., Lei, B., Liang, W., Gong, J., Zhao, C., Yu, J., Li, X., Tang, B., Yuan, S."DADLE improves hepatic ischemia/reperfusion injury in mice via activation of the Nrf2/HO‑1 pathway". Molecular Medicine Reports 16.5 (2017): 6214-6221.
Chicago
Zhou, Y., Zhang, J., Lei, B., Liang, W., Gong, J., Zhao, C., Yu, J., Li, X., Tang, B., Yuan, S."DADLE improves hepatic ischemia/reperfusion injury in mice via activation of the Nrf2/HO‑1 pathway". Molecular Medicine Reports 16, no. 5 (2017): 6214-6221. https://doi.org/10.3892/mmr.2017.7393